Success Story Nuance Communications, Inc. (NASDAQ: NUAN), recently announced a success story at Einstein Healthcare in Philadelphia, where VIDA's LungPrint Discovery was deployed through the Nuance AI Marketplace, into PowerScribe™ One. Einstein Healthcare has already processed nearly 1,400 studies using LungPrint Discovery to address the diagnostic challenges of the COVID-19
Todd Johnson joins VIDA, bringing expertise in enterprise imaging, clinical software applications to growing bench of experts for AI-powered pulmonary imaging company Coralville, IA (July 7, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced today that Todd Johnson has joined the company as chief
At VIDA, Black lives matter. As a respiratory AI company, we are entrenched in the public health impact of COVID-19, which has laid bare the racial inequities in access to healthy foods, safe working conditions, medical treatment and a host of other social determinants that negatively impact public health. Black
A Discussion Between Thoracic Radiologist John Newell, MD, and VIDA CEO Susan Wood, PhD On May 1, 2020, during AuntMinnie's 2020 Virtual Conference, Dr. Newell and Dr. Wood discussed the evolving role of imaging for COVID-19 and the importance of a holistic, quantitative approach to managing patients with respiratory conditions.
$2M Second Close from Strategic Partners Completes $13M C Round to Advance AI-Powered Respiratory Solutions Coralville, IA (April 15, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, received $2M from OSF Ventures, the corporate investment arm of OSF HealthCare, as a second close of its C
VIDA provides personalized care solutions that can help pulmonologists identify specific disease phenotypes as well as decide on the most appropriate treatments Note: The following press release was issued by Frost and Sullivan on April 1, 2020 and is republished here in full. SANTA CLARA, Calif., April 1, 2020 /CNW/ -- Based
We’d like to start off by expressing our heartfelt gratitude to the men and women in healthcare who are braving this storm, putting themselves and their families at risk for their commitment to the health and well-being of their patients‒ we see you, we support you and we want to
Anthony Chang, MD, MBA, MPH, MS is a pediatric cardiologist and Chief Intelligence and Innovation Officer at CHOC Children's Orange County. He is also the founder of AIMed (Artificial Intelligence in Medicine), a media enterprise focused on artificial intelligence (AI). Dr. Chang sat down with VIDA's CEO, Susan Wood, PhD, to
With the rising concerns of COVID-19 disease (SARS-CoV-2 coronavirus) spreading throughout the global community, the VIDA team wants to assure our customers and partners that we have taken steps to adapt to the worldwide crisis. The health and wellbeing of our employees, partners, customers, and the community is our top
Coralville, IA (March 12, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, today announced an $11M initial close of its Series C financing. The investment was led by First Analysis Corporation with initial equity participation from Blue Heron Capital and UnityPoint Health Ventures. Existing investors including
